Home
Live Updates
Dr Richardson on the UPLIFT Trial of Upifitamab Rilsodotin in Ovarian Cancer : vimarsana.com
Dr Richardson on the UPLIFT Trial of Upifitamab Rilsodotin in Ovarian Cancer
Debra L. Richardson, MD, FACS, FACOG, discusses outcomes seen with upifitamab rilsodotin in the phase 1/2 UPLIFT trial for patients with ovarian cancer.
Related Keywords
Oklahoma ,
United States ,
University Of Oklahoma ,
Debral Richardson ,
,
Phasei Program ,
University Of Oklahoma Ou College Medicine ,
Stephenson Cancer Center ,
Ou Health ,
Gynecologic Oncology ,
vimarsana.com © 2020. All Rights Reserved.